Ayurvedic Drug Trail on BPH

Ultrasonographic analysis of prostate response in Haritakyadi kwatha in patient with BPH (Benign Prostatic Hyperplasia) - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106738

Enrollment

Registered

2026-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: the patient having 3 or more than 3 sign and symptoms of BPH

Exclusion criteria

Exclusion criteria: Patients of age below 40 years and above 70 years Patients of Malignancy, Congenital deformities of urogenital tract Systemic disease like Chronic renal failure, uncontrolled hypertension, diabetes mellitus patients having Hematuria , bladder infection, kidney stones. Urethral Stricture. Adenocarcinoma of prostate

Design outcomes

Primary

Measure	Time frame
Haritkyadi kwath significantly reduce BPH symptoms (IPSS score)and ultrasonographic changesTimepoint: 8 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Anil Kumar

IMS BHU

dranilkumar146@gmail.com8948538522

Outcome results